Felipe Pires, a patient with SCA2 ataxia, is the first person with ataxia to take first place in a jiu-jitsu world championship, and likely in any sport.
Vico Therapeutics informs that the first dose was administered to a human patient in the clinical trial (Phase 1/2a) of the drug VO659 for ataxias SCA1 and SCA3 and for Huntington's Disease (HD).